Hemorrhage control in the battlefield

Role of new hemostatic agents

Hasan B. Alam, David Burris, Joseph A. Dacorta, Peter M Rhee

Research output: Contribution to journalArticle

181 Citations (Scopus)

Abstract

Uncontrolled hemorrhage is the leading cause of preventable combat-related deaths. The vast majority of these deaths occur in the field before the injured can be transported to a treatment facility. Early control of hemorrhage remains the most effective strategy for treating combat casualties. A number of hemostatic agents have recently been deployed to the warfront that can be used to arrest bleeding before surgical control of the source. The purpose of this article is to summarize the background information regarding these hemostatic agents, indications and rationale for their use, and characteristics of these products that may impact effectiveness.

Original languageEnglish (US)
Pages (from-to)63-69
Number of pages7
JournalMilitary Medicine
Volume170
Issue number1
StatePublished - Jan 2005
Externally publishedYes

Fingerprint

Hemostatics
Hemorrhage

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health

Cite this

Alam, H. B., Burris, D., Dacorta, J. A., & Rhee, P. M. (2005). Hemorrhage control in the battlefield: Role of new hemostatic agents. Military Medicine, 170(1), 63-69.

Hemorrhage control in the battlefield : Role of new hemostatic agents. / Alam, Hasan B.; Burris, David; Dacorta, Joseph A.; Rhee, Peter M.

In: Military Medicine, Vol. 170, No. 1, 01.2005, p. 63-69.

Research output: Contribution to journalArticle

Alam, HB, Burris, D, Dacorta, JA & Rhee, PM 2005, 'Hemorrhage control in the battlefield: Role of new hemostatic agents', Military Medicine, vol. 170, no. 1, pp. 63-69.
Alam, Hasan B. ; Burris, David ; Dacorta, Joseph A. ; Rhee, Peter M. / Hemorrhage control in the battlefield : Role of new hemostatic agents. In: Military Medicine. 2005 ; Vol. 170, No. 1. pp. 63-69.
@article{e2b908be20554188b7bd2ed0f1884e6d,
title = "Hemorrhage control in the battlefield: Role of new hemostatic agents",
abstract = "Uncontrolled hemorrhage is the leading cause of preventable combat-related deaths. The vast majority of these deaths occur in the field before the injured can be transported to a treatment facility. Early control of hemorrhage remains the most effective strategy for treating combat casualties. A number of hemostatic agents have recently been deployed to the warfront that can be used to arrest bleeding before surgical control of the source. The purpose of this article is to summarize the background information regarding these hemostatic agents, indications and rationale for their use, and characteristics of these products that may impact effectiveness.",
author = "Alam, {Hasan B.} and David Burris and Dacorta, {Joseph A.} and Rhee, {Peter M}",
year = "2005",
month = "1",
language = "English (US)",
volume = "170",
pages = "63--69",
journal = "Military Medicine",
issn = "0026-4075",
publisher = "Association of Military Surgeons of the US",
number = "1",

}

TY - JOUR

T1 - Hemorrhage control in the battlefield

T2 - Role of new hemostatic agents

AU - Alam, Hasan B.

AU - Burris, David

AU - Dacorta, Joseph A.

AU - Rhee, Peter M

PY - 2005/1

Y1 - 2005/1

N2 - Uncontrolled hemorrhage is the leading cause of preventable combat-related deaths. The vast majority of these deaths occur in the field before the injured can be transported to a treatment facility. Early control of hemorrhage remains the most effective strategy for treating combat casualties. A number of hemostatic agents have recently been deployed to the warfront that can be used to arrest bleeding before surgical control of the source. The purpose of this article is to summarize the background information regarding these hemostatic agents, indications and rationale for their use, and characteristics of these products that may impact effectiveness.

AB - Uncontrolled hemorrhage is the leading cause of preventable combat-related deaths. The vast majority of these deaths occur in the field before the injured can be transported to a treatment facility. Early control of hemorrhage remains the most effective strategy for treating combat casualties. A number of hemostatic agents have recently been deployed to the warfront that can be used to arrest bleeding before surgical control of the source. The purpose of this article is to summarize the background information regarding these hemostatic agents, indications and rationale for their use, and characteristics of these products that may impact effectiveness.

UR - http://www.scopus.com/inward/record.url?scp=15944366571&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=15944366571&partnerID=8YFLogxK

M3 - Article

VL - 170

SP - 63

EP - 69

JO - Military Medicine

JF - Military Medicine

SN - 0026-4075

IS - 1

ER -